Xilio Therapeutics Inc. Gains 22.77%
Fri, Sep 09, 2022 at 07:23 PM
Xilio Therapeutics Inc. (XLO:NASDAQ) soared at $2.75, representing a gain of 22.8%. On Fri, Sep 09, 2022, XLO:NASDAQ hit a New 2-Week High of $2.75. The stock appeared on our News Catalysts scanner on Tue, Sep 06, 2022 at 04:54 PM in the 'MISCELLANEOUS' category. From Fri, Aug 26, 2022, the stock recorded 22.22% Up Days and 30.00% Green Days
About Xilio Therapeutics Inc. (XLO:NASDAQ)
Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer.
Top 10 Gainers:
- Digital Media Solutions Inc. Class A (DMS:NYSE), 71.88%
- Aditxt Inc. (ADTX:NASDAQ), 37%
- Trinity Place Holdings Inc. (TPHS:NYSEMKT), 33.79%
- American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 31.09%
- MOGU Inc. (MOGU:NYSE), 29.82%
- Shuttle Pharmaceuticals Holdings Inc. (SHPH:NASDAQ), 26.14%
- Invitae Corporation (NVTA:NYSE), 25%
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 24.24%
- Xilio Therapeutics Inc. (XLO:NASDAQ), 22.77%
- Veru Inc. (VERU:NASDAQ), 21.93%